Death receptors, NF-kappa B activation and apoptosis: the potential for therapeutic intervention.
Farrow
S N
SN
Cell Biology Unit, GlaxoWellcome, Stevenage, Herts., U.K.
D017209:Apoptosis / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000628:therapy; D016328:NF-kappa B / Q000378:metabolism*; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology*; D014764:Viral Proteins / Q000502:physiology; D014777:Virus Diseases / Q000628:therapy
D016328:NF-kappa B; D018124:Receptors, Tumor Necrosis Factor; D014764:Viral Proteins